FIELD: chemistry.
SUBSTANCE: invention claims compounds of the formula (I) with radicals as described in the claim, and medicine with inhibition effect on glycine absorption, based on compound of the formula (I) 
.
EFFECT: medicine for diseases treatment where glycine absorption inhibition can be effective.
21 cl, 1 tbl, 173 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 1-(2-AMINOBENZOL)PIPERAZINE DERIVATIVES AS GLYCIN UPTAKE INHIBITORS TO BE USED FOR PSYCHOSIS TREATMENT | 2004 |
|
RU2354653C2 |
| PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | 2004 |
|
RU2326118C2 |
| COMPOUNDS AND COMPOSITIONS AS CANNABINOID RECEPTOR 1 INHIBITORS | 2005 |
|
RU2431635C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR | 2005 |
|
RU2388476C2 |
| CYCLOPENTA(D)PYRIMIDINES AS PROTEIN KINASE AKT INHIBITORS | 2007 |
|
RU2481336C2 |
| CIS-2,4,5-TRIPHENYLIMIDAZOLINES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2305095C2 |
| COMPOUNDS AND COMPOSITIONS AS ITPKb INHIBITORS | 2007 |
|
RU2425826C2 |
| NOVEL PYRIMIDINE DERIVATIVE AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND CANCER | 2021 |
|
RU2825827C1 |
| DISUBSTITUTED PYRAZOLOBENZODIAZEPINES USED AS CDK2 AND ANGIOGENESIS INHIBITORS, AS WELL AS FOR TREATING MALIGNANT GROWTHS IN MAMMARY GLANDS, LARGE INTESTINES, LUNGS AND PROSTATE GLANDS | 2005 |
|
RU2394826C2 |
| PHARMACEUTICAL COMBINATIONS CONTAINING PYRIDO[4,3-d]PYRIMIDINE DERIVATIVES AS HSP90 INHIBITOR AND HER2 INHIBITOR | 2009 |
|
RU2532375C2 |
